RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Overview Fund Activity
Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

74 hedge funds and large institutions have $1.01B invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+23
Holders Change %
+45.1%
% of All Funds
1.14%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
27
Increased
34
Reduced
5
Closed
4
Calls
$7.38M
Puts
$67K
Net Calls
+$7.31M
Net Calls Change
+$7.31M

Top Buyers

1
BlackRock
1
BlackRock
New York
$85.4M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$47.2M
3
State Street
3
State Street
Massachusetts
$17.5M
4
Norges Bank
4
Norges Bank
Norway
$23.9M
5
FAM
5
Fred Alger Management
New York
$6.82M

Top Sellers

1
CA
1
CHI Advisors
New York
$69.3M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$5.32M
3
SCM
3
Suvretta Capital Management
New York
$0
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$0
5
PA
5
Perceptive Advisors
New York
$125M
Name Holding Trade Value Shares
Change 		Shares
Change %
Adage Capital Partners
76
Adage Capital Partners
Massachusetts
– -$8.24M -347,315 Closed
LP
77
LMR Partners
United Kingdom
– -$1.19M -50,000 Closed
E
78
Ergoteles
New York
– -$208K -8,791 Closed
1 2 3
4